Apogee Therapeutics, Inc. (NASDAQ: APGE) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT APOGEE THERAPEUTICS, INC.

Apogee Therapeutics, Inc. (NASDAQ: APGE)
Listen to this Section


$132.63
-0.0550 ( -0.04% ) 2.7M

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Market Data


Open $132.63
Previous Close $132.68
Volume 2.7M
Market Cap $9.98B
Day Range $132.62 - $133.55
52 Week Range $34.34 - $133.55
Shares Outstanding 75.18M
Change % -0.04%
Net Change ▼ -0.0550
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
IPO Year2023
CountryUnited States
UnderwriterJefferies, TD Cowen, Stifel, Guggenheim Securities, Wedbush Securities, more

Insider Ownership Transactions

Total Amount Purchased: 365,853.00

Date Type Amount Purchased Purchaser
2025-10-15 Buy 365853.00 Shah Nimish P

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 06, 2025

Latest News